Phase 1 Alopecia Areata Clinical Trials

6 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–6 of 6 trials

Recruiting

Phase 1

Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration

HealthySevere Alopecia AreataActive Non-segmental Vitiligo

Innovent Biologics (Suzhou) Co. Ltd.160 enrolled1 locationNCT07554222

Recruiting

Phase 1Phase 2

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata

Alopecia Areata (AA)

Aldena Therapeutics24 enrolled7 locationsNCT06826196

Recruiting

Phase 1

A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo

Alopecia AreataVitiligo

Dren Bio80 enrolled20 locationsNCT06602232

Recruiting

Phase 1

A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.

Alopecia Areata

Forte Biosciences, Inc.32 enrolled6 locationsNCT07205159

Recruiting

Phase 1

A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

Systemic Lupus Erythematosus (SLE)Alopecia Areata (AA)Immune-mediated Focal Segmental Glomerulosclerosis (FSGS)

Otsuka Pharmaceutical Development & Commercialization, Inc.30 enrolled6 locationsNCT06799520

Recruiting

Phase 1Phase 2

Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser

Alopecia Areata

Egymedicalpedia70 enrolled1 locationNCT06239324